DEC 15, 2015 7:50 AM PST

A Light-Sound Scan to Replace Lymph Node Biopsies?

WRITTEN BY: Xuan Pham
Instead of invasive biopsies, doctors could soon detect melanoma metastasis with a handheld scanning device. A team of researchers from Germany may have found a way to replace risky biopsies with audio-visual imaging techniques that detect cancer’s spread in the body.
 
Noninvasive technique shows promise for detecting skin cancer metastasis

Melanoma is the deadliest form of skin cancer caused by ultraviolet radiation damages to the skin cells. According to the Skin Cancer Foundation, melanoma kills over 9,000 Americans each year, making it the fifth most common cancer in the U.S.

According to the Melanoma Research Foundation, the most dangerous aspect of melanoma is its ability to metastasize – using the body’s lymph nodes to spread to distant sites like the liver, lung, bones, and brain. Thus, enlarged or abnormal lymph nodes can alert doctors of the cancer’s spread. But melanoma can also spread quietly, and even without enlargement, doctors perform a pre-emptive procedure known as sentinel lymph node biopsy (SLNB) to “grade” the cancer and check for metastasis.
 

The SLNB procedure involves injection of a radioactive substance or dye near the tumor to locate the position of the sentinel lymph node. Following the path of radioactivity or dye trail, the surgeons land upon the “sentinel” nodes, which get removed and analyzed for cancer presence.

This biopsy procedure detects metastatic melanoma in only about a third of patients; yet the procedure puts all patients at risk for infection and nerve damage to the head and neck area.

Researchers hope the new technique will bypass the biopsy all together.

The technique, called multispectral opto-acoustic tomography (MSOT), uses light and sound to locate rogue melanin pigments in the sentinel lymph nodes. Instead of radioactive materials, researchers inject a green dye into the primary tumor site. Then the handheld MSOT illuminates the patient’s tissues with light pulses at multiple wavelengths, allowing researchers to track the dye’s path to sentinel nodes.
At the nodes, the device generates an ultrasound signal at the presence of melanin. Melanin pigment is produced only by melanoma cells, and its presence in the lymph nodes indicates that the melanoma has metastasized. Conversely no melanin indicates absence of metastasis, and prevents further unnecessary procedures.

The researchers tested the MSOT technique in 506 lymph node biopsies removed from 214 melanoma patients. Their technique reportedly outperformed the conventional diagnostic approach at correctly identifying cancer metastasis by 8.7%. Then in a group of 20 melanoma patients who had yet received surgery, the MSOT technique correctly visualized 100% cases of metastasis, ruling out cancer spread in more than 50% of patients.  

A non-invasive and non-radioactive way to detect cancer metastasis sounds great! But is this technique good enough to replace biopsies? Not just yet. Though they reported 100% sensitivity, i.e. no false negatives, the specificity is low at 48-62%, meaning that around half of cases are identified as false positives. Ultimately, the researchers have to demonstrate that this technique is as good as lymph node surgery, and they can only do so with repeated trials in a much larger study size.

Source: Science Translational Medicine, Medline release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 11, 2019
Clinical & Molecular DX
AUG 11, 2019
New Device Improves Accuracy In Lung Cancer Diagnosis
Acute respiratory distress syndrome ARDS occurs when fluid builds up in the alveoli. These tiny elastics sacs, which are responsible for gaseous exchange i...
SEP 13, 2019
Clinical & Molecular DX
SEP 13, 2019
Apple Watch New Research App: A Boon to Women's Health
The Apple company, in 2018, enrolled more than 400,000 people in its Apple Heart Study conducted in partnership with Stanford University researchers....
OCT 14, 2019
Genetics & Genomics
OCT 14, 2019
Researchers Develop a Score to Quantify the Risk of Epilepsy
It usually takes two seizures before a person can be diagnosed with epilepsy. New work can help change that....
NOV 05, 2019
Cannabis Sciences
NOV 05, 2019
Single Exposure to CBD & THC Disrupts Embryonic Development
It only takes one incidence of cannabinoid exposure during the first month of pregnancy to yield detrimental effects on a developing embryo. New research r...
DEC 05, 2019
Clinical & Molecular DX
DEC 05, 2019
Catching drug-resistant HIV mutants with next generation sequencing
Human immunodeficiency virus (HIV)-positive individuals are treated with antiretroviral therapies to reduce the amount of circulating virus, restore their...
FEB 06, 2020
Clinical & Molecular DX
FEB 06, 2020
Concussion detector could pick up concussions in athletes, right from the sidelines
Concussions are brain traumas caused by a blow to the head or a whiplash injury. The risk of concussions are greatly heightened in athletes playing high co...
Loading Comments...